Akums Drugs and Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Akums Drugs and Pharmaceuticals has a total shareholder equity of ₹28.5B and total debt of ₹4.6B, which brings its debt-to-equity ratio to 16.1%. Its total assets and total liabilities are ₹42.7B and ₹14.2B respectively. Akums Drugs and Pharmaceuticals's EBIT is ₹3.2B making its interest coverage ratio 8.4. It has cash and short-term investments of ₹7.9B.
Key information
16.1%
Debt to equity ratio
₹4.59b
Debt
| Interest coverage ratio | 8.4x |
| Cash | ₹7.95b |
| Equity | ₹28.47b |
| Total liabilities | ₹14.23b |
| Total assets | ₹42.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AKUMS's short term assets (₹26.2B) exceed its short term liabilities (₹12.3B).
Long Term Liabilities: AKUMS's short term assets (₹26.2B) exceed its long term liabilities (₹1.9B).
Debt to Equity History and Analysis
Debt Level: AKUMS has more cash than its total debt.
Reducing Debt: Insufficient data to determine if AKUMS's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AKUMS's debt is well covered by operating cash flow (110.2%).
Interest Coverage: AKUMS's interest payments on its debt are well covered by EBIT (8.4x coverage).